ARTL
Artelo Biosciences·NASDAQ
--
--(--)
--
--(--)
2.57 / 10
Underperform
Technical analysis yields 2.57/10, manifesting challenging technical structure. Affirmative signals in no significant factors conflict with discouraging patterns in Long Lower Shadow, Long Upper Shadow, and Marubozu White. Technical assessment: cautious.
Analysis Checks(0/3)
Long Lower Shadow
Score2.97/10
Win Rate46.15%
Hist. Signals65
Avg Return1.10%
Score2.97/10
Win Rate46.15%
Hist. Signals65
Avg Return1.10%
Marubozu White
Score1.5/10
Win Rate33.33%
Hist. Signals33
Avg Return4.55%
Score1.5/10
Win Rate33.33%
Hist. Signals33
Avg Return4.55%
Long Upper Shadow
Score3.25/10
Win Rate45.00%
Hist. Signals80
Avg Return6.94%
Score3.25/10
Win Rate45.00%
Hist. Signals80
Avg Return6.94%
Long Lower Shadow
Score2.97/10
Win Rate46.15%
Hist. Signals65
Avg Return1.10%
Score2.97/10
Win Rate46.15%
Hist. Signals65
Avg Return1.10%
Long Upper Shadow
Score3.25/10
Win Rate45.00%
Hist. Signals80
Avg Return6.94%
Score3.25/10
Win Rate45.00%
Hist. Signals80
Avg Return6.94%
Marubozu White
Score1.5/10
Win Rate33.33%
Hist. Signals33
Avg Return4.55%
Score1.5/10
Win Rate33.33%
Hist. Signals33
Avg Return4.55%
What is the current technical signals for ARTL?
- ARTL presents a Underperform setup with a Technical Score of 2.57/10. Key technical indicators highlight an RSI of 42.18 and a MACD of -0.05, with the trend anchored by the 50-Day SMA at 1.64. Traders should monitor key support at 1.29 and resistance at 1.50.
